Although Dkk-1 functions as a naturally occurring negative regulator of Wnt signaling, Dkk-1 expression is often associated with poor prognosis in gastrointestinal cancers, and Dkk-1 blocking antibodies can inhibit tumor growth in pre-clinical animal models (Kagey & He, 2017). This evidence concerns the gene DKK1 and neoplasm.